MMedication Read More Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s StelaraNovember 6, 2025 In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
MMedication Read More Launch prices for new drugs ‘significantly’ exceed inflation, analysis saysOctober 23, 2025 Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
MMedication Read More Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer lookSeptember 14, 2025 Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…
HHealthcare Read More US drug pricing shake-up threatens access to medicines in Europe – POLITICOAugust 20, 2025 For European drugmakers there are still many unknowns about how the MFN scheme — and overall tariffs on…